Skip to main content

Cardiopulmonary Bypass clinical trials at UCSF

2 in progress, 0 open to eligible people

Showing trials for
  • ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE

    Sorry, not currently recruiting here

    The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac surgery with CPB.

    San Francisco, California and other locations

  • DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)

    Sorry, not currently recruiting here

    A randomized, parallel group, active comparator-controlled trial to evaluate the non-inferiority or superiority of Cryopreserved Platelets with Liquid Stored Platelets in controlling blood loss in patients undergoing Cardiopulmonary Bypass Surgery.

    San Francisco, California and other locations

Our lead scientists for Cardiopulmonary Bypass research studies include .

Last updated: